Similar Articles
1821 Individualized peri-operative fluid therapy facilitating early-phase recovery after liver transplantation
1822 Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells
1823 Diazoxide attenuates ischemia/reperfusion injury via upregulation of heme oxygenase-1 after liver transplantation in rats
1824 Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression
1825 Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma
1826 Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis
1827 Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma
1828 Chronic bile duct hyperplasia is a chronic graft dysfunction following liver transplantation
1829 Prophylaxis of chronic kidney disease after liver transplantation - experience from west China
1830 Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA